Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan

por Sawaki, Masataka, Muramatsu, Yasuaki, Togo, Kanae, Iwata, Hiroji
Publicado 2023

Palbociclib‐letrozole as first‐line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study

por Takahashi, Masato, Masuda, Norikazu, Nishimura, Reiki, Inoue, Kenichi, Ohno, Shinji, Iwata, Hiroji, Hashigaki, Satoshi, Muramatsu, Yasuaki, Umeyama, Yoshiko, Toi, Masakazu
Publicado 2020

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

por Masuda, Norikazu, Mukai, Hirofumi, Inoue, Kenichi, Rai, Yoshiaki, Ohno, Shinji, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Umeyama, Yoshiko, Iwata, Hiroji, Toi, Masakuzu
Publicado 2019

Palbociclib in combination with letrozole as first‐line treatment for advanced breast cancer: A Japanese phase II study

por Masuda, Norikazu, Nishimura, Reiki, Takahashi, Masato, Inoue, Kenichi, Ohno, Shinji, Iwata, Hiroji, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Nagasawa, Takashi, Umeyama, Yoshiko, Toi, Masakazu
Publicado 2018

Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib...

por Masuda, Norikazu, Mukai, Hirofumi, Inoue, Kenichi, Rai, Yoshiaki, Ohno, Shinji, Ohtani, Shoichiro, Shimizu, Chikako, Hashigaki, Satoshi, Muramatsu, Yasuaki, Umeyama, Yoshiko, Iwata, Hiroji, Toi, Masakazu
Publicado 2020

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup...

por Masuda, Norikazu, Inoue, Kenichi, Nakamura, Rikiya, Rai, Yoshiaki, Mukai, Hirofumi, Ohno, Shinji, Hara, Fumikata, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Nagasawa, Takashi, Umeyama, Yoshiko, Huang, Xin, Iwata, Hiroji
Publicado 2018

Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup a...

por Mukai, Hirofumi, Shimizu, Chikako, Masuda, Norikazu, Ohtani, Shoichiro, Ohno, Shinji, Takahashi, Masato, Yamamoto, Yutaka, Nishimura, Reiki, Sato, Nobuaki, Ohsumi, Shozo, Iwata, Hiroji, Mori, Yuko, Hashigaki, Satoshi, Muramatsu, Yasuaki, Nagasawa, Takashi, Umeyama, Yoshiko, Lu, Dongrui R., Toi, Masakazu
Publicado 2018